Biopharma Business

Tag "Cancer"

Anti-Pancreatic Cancer Drug In Research Focus

    Anti-Pancreatic Cancer Drug In Research Focus

Intriguing antitumor activity is found in a very promising class of natural compounds: cyclic depsipeptides, which have a challenging structure that makes their investigation difficult. Now, Chinese scientists have established

Read Full Article

NIH launches $215m partnership for cancer immunotherapy strategies

    NIH launches $215m partnership for cancer immunotherapy strategies

The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot… The National Institutes of Health (NIH)

Read Full Article

Alcohol aversion drug Disulfiram may combat chemotherapy resistance

    Alcohol aversion drug Disulfiram may combat chemotherapy resistance

Scientists have had positive results from a laboratory-based study using a well-known alcohol aversion drug disulfiram, to combat chemotherapy resistance in the most common type of lung cancer, non-small cell

Read Full Article

Successor to PD-1 inhibitors the focus of cancer immunotherapy

    Successor to PD-1 inhibitors the focus of cancer immunotherapy

The cancer immunotherapy pipeline, displays a high level of first-in-class innovation with novel developments focusing heavily on producing the next big immune checkpoint inhibitor, according to GBI Research. GBI Research’s

Read Full Article

Exclusive access to Cancer Research UK’s inhibitor payload granted to Glythera

    Exclusive access to Cancer Research UK’s inhibitor payload granted to Glythera

The antibody drug conjugate (ADC) development company, Glythera, has been granted exclusive, worldwide rights to Cancer Research UK’s novel CDK11 inhibitor programme for the development of multiple ADCs. Under the

Read Full Article

Pfizer gifts the NHS with breast cancer drug

Pfizer has announced it will provide its breast cancer drug, palbociclib — which has been provisionally rejected by NICE for routine use as a result of cost — to the

Read Full Article

New biomarkers for bowel cancer treatment

One of Europe’s largest collaborative academic-industry research projects, designed to develop and assess novel approaches for identification of new markers for colon cancer, has been conducted by public-private consortium OncoTrack.

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements